Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Myeloperoxidase directs properdin-mediated complement activation.

O'Flynn J, Dixon KO, Faber Krol MC, Daha MR, van Kooten C.

J Innate Immun. 2014;6(4):417-25. doi: 10.1159/000356980. Epub 2013 Dec 20.

2.

Both complement and IgG fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in mice.

Otten MA, Groeneveld TW, Flierman R, Rastaldi MP, Trouw LA, Faber-Krol MC, Visser A, Essers MC, Claassens J, Verbeek JS, van Kooten C, Roos A, Daha MR.

J Immunol. 2009 Sep 15;183(6):3980-8. doi: 10.4049/jimmunol.0901301. Epub 2009 Aug 26.

3.

Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy.

Oortwijn BD, Roos A, Royle L, van Gijlswijk-Janssen DJ, Faber-Krol MC, Eijgenraam JW, Dwek RA, Daha MR, Rudd PM, van Kooten C.

J Am Soc Nephrol. 2006 Dec;17(12):3529-39. Epub 2006 Oct 18.

4.

Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins.

Groeneveld TW, Oroszlán M, Owens RT, Faber-Krol MC, Bakker AC, Arlaud GJ, McQuillan DJ, Kishore U, Daha MR, Roos A.

J Immunol. 2005 Oct 1;175(7):4715-23.

5.

Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency.

Roos A, Garred P, Wildenberg ME, Lynch NJ, Munoz JR, Zuiverloon TC, Bouwman LH, Schlagwein N, Fallaux van den Houten FC, Faber-Krol MC, Madsen HO, Schwaeble WJ, Matsushita M, Fujita T, Daha MR.

Eur J Immunol. 2004 Sep;34(9):2589-98.

6.
7.

Functional characterization of the lectin pathway of complement in human serum.

Roos A, Bouwman LH, Munoz J, Zuiverloon T, Faber-Krol MC, Fallaux-van den Houten FC, Klar-Mohamad N, Hack CE, Tilanus MG, Daha MR.

Mol Immunol. 2003 Jan;39(11):655-68.

PMID:
12493641
8.

Specific inhibition of the classical complement pathway by C1q-binding peptides.

Roos A, Nauta AJ, Broers D, Faber-Krol MC, Trouw LA, Drijfhout JW, Daha MR.

J Immunol. 2001 Dec 15;167(12):7052-9.

9.

Human IgA activates the complement system via the mannan-binding lectin pathway.

Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR.

J Immunol. 2001 Sep 1;167(5):2861-8.

11.

Inhibition of activation of the classical pathway of complement by human neutrophil defensins.

van den Berg RH, Faber-Krol MC, van Wetering S, Hiemstra PS, Daha MR.

Blood. 1998 Nov 15;92(10):3898-903.

PMID:
9808583
12.

Anti-C1q receptor/calreticulin autoantibodies in patients with systemic lupus erythematosus (SLE).

van den Berg RH, Siegert CE, Faber-Krol MC, Huizinga TW, van Es LA, Daha MR.

Clin Exp Immunol. 1998 Feb;111(2):359-64.

13.

Intracellular localization of the human receptor for the globular domains of C1q.

van den Berg RH, Prins F, Faber-Krol MC, Lynch NJ, Schwaeble W, van Es LA, Daha MR.

J Immunol. 1997 Apr 15;158(8):3909-16.

PMID:
9103461
14.

Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.

van den Berg RH, Faber-Krol MC, van de Klundert JA, van Es LA, Daha MR.

J Immunol. 1996 Jun 1;156(11):4466-73.

PMID:
8666822

Supplemental Content

Loading ...
Support Center